Advaxis, Inc. Gains 25.11%
Fri, Jan 28, 2022 at 05:30 PM
Advaxis, Inc. (ADXS:NASDAQ) jumped higher at $0.15, a gain of 25.1%. On Thu, Jan 27, 2022, ADXS:NASDAQ hit a New 2-Week Low of $0.12. The stock appeared on our News Catalysts scanner on Fri, Jan 28, 2022 at 09:54 AM in the 'PRIVATE PLACEMENT' category. From Thu, Jan 13, 2022, the stock recorded 0.00% Up Days and 0.00% Green Days
The stock spiked on Tue, Jan 04, 2022 at $0.19 with a volume of 1M+.
About Advaxis, Inc. (ADXS:NASDAQ)
Advaxis Inc focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies.
Top 10 Gainers:
- Knightscope Inc. (KSCP:NASDAQ), 175.63%
- Option Care Health, Inc. (BIOS:NASDAQ), 100%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 87.93%
- Yoshitsu Co. Ltd (TKLF:NASDAQ), 33.33%
- Advaxis, Inc. (ADXS:NASDAQ), 25.11%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 23.67%
- Vaccinex, Inc. (VCNX:NASDAQ), 23.5%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 23.35%
- Provention Bio, Inc. (PRVB:NASDAQ), 22.35%
- Rallybio Corporation (RLYB:NASDAQ), 21.54%